Trial intelligence / Profile preview

Comparative study of corticosteroid vs botulinum toxin injections for plantar fasciitis

2018-002929-36Phase 3Active

Sponsor
Dra. Virginia Raquel Céspedes Nava
Start
Sep 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of botulinum toxin type A and triamcinolone acetonide in plantar fasciitis (2 arms), sponsored by Dra. Virginia Raquel Céspedes Nava. Primary endpoint: Pain reduction on EVA scale. Started Sep 2018; status: active.

02

Drugs

botulinum toxin type Atriamcinolone acetonide
03

Conditions

plantar fasciitis

Beyond the preview

Go deeper on 2018-002929-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-002929-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call